Department of Medicine
Faculty Profiles by Division

Division of Hematology/Oncology

Faculty Profiles

[Return To Index page]
photo Antoinette Wozniak, MD, FACP, FASCO

Hematology/Oncology

Visiting Professor of Medicine

Associate Director of Clinical Research, UPMC Hillman Cancer Center

Director, Lung Cancer Disease Unit

Co-Director, UPMC Lung Cancer Center of Excellence

Email: wozniakaj@upmc.edu

Phone: 412-623-2696

Contact
Office: 5150 Centre Avenue
UPMC Cancer Pavilion, 5th Floor, Room 568
Pittsburgh, PA 15232
 
Phone: 412-623-2696
Fax: 412-648-6579
E-mail: wozniakaj@upmc.edu
Administrative Assistant:
Lois Malehorn
Address: 5150 Centre Avenue
UPMC Cancer Pavilion, 5th floor, 570
Pittsburgh, PA 15232
Email: malehornlm@upmc.edu
Phone: 412-648-6589
Fax: 412-648-6579
Education and Training
Education
BS, Niagara University, 1973
MD, State University of New York at Buffalo, NY, 1977
Training
Intern, SUNY at Buffalo Affiliated Hospitals, 1978
Residency - Chief Medical Resident, SUNY at Buffalo Affiliated Hospitals, Buffalo, NY, 1980
Fellowship, University of Florida, Department of Medicine, Gainesville, FL, 1983
Research Interest
Dr. Wozniak has been involved in multiple clinical trials both in a primary role and as a co-investigator, including national trials from the Southwest Oncology Group, NCI sponsored studies, and pharmaceutical trials. The focus of my clinical research has been in lung cancer, and mesothelioma, Dr. Wozniak also previously collaborated on observational and secondary data analysis focused studies of lung cancer. Currently, Dr. Wozniak serves as the Associate Director of Clinical Research, Hillman Cancer Center. In these roles she is responsible for the vision and strategic planning for all oncology-related clinical research and the development of the clinical lung cancer program. Dr. Wozniak continues to conduct quality clinical research particularly in thoracic malignancies.
Clinical Interest
Dr. Wozniak has been a clinical medical oncologist for over 30 years. Her clinical interests are Lung Cancer (Small Cell and Non-Small Cell), Mesothelioma and Thymus Gland Cancer.
Publications
Selected Publications:
Wozniak, AJ, Schwartz AG. The risk of second primary lung cancer: an unsolved dilemma. Transl Lung Cancer Res. Transl Lung Cancer. 2018; Suppl 2: 54-556.
Paximadis P, Beebe-Dimmer JL, George J, Schwartz AG, Wozniak A, Gadgeel S. Comparing treatment strategies for stage I small-cell lung cancer. Clin Lung Cancer. Clin Lung Cancer. 2018; 19(5): e559-e565.
Thakur MK, Ruterbusch JJ, Schwartz AG, Gadgeel SM, Beebe-Dimmer JL, Wozniak AJ. Risk of second lung cancer in patients with previously treated lung cancer: analysis of surveillance, epidemiology and end results (SEER) data. J Thorac Oncol. 2018; 13(1): 46-53.
Schneider BJ, Kalemkerian GP, Gadgeel SM, Valdivieso M, Hackstock DM, Chen W, Heilbrun LK, Ruckdeschel JC, Wozniak AJ. Phase II trial of dose-dense pemetrexed, gemcitabine, and bavacizumab in patients with advanced, non-small-cell lung cancer. Clin Lung Cancer. 2017; 18(3): 299-302.
Gadgeel SM, Pennell NA, Fidler MJ, Halmos B, Bonomi P, Stevenson J, Schneider B, Sukari A, Ventimiglia J, Chen W, Galasso C, Wozniak A, Boerner J, Kalemkerian GP. Phase II study of maintenance pembrolizumab in patients with extensive-stage small cell lung cancer (SCLC). J Thorac Oncol. 2018; 13(9): 1393-1399.
Wozniak AJ, Schwartz AG. Risk of second lung cancer in patients with previously treated lung cancer: analysis of surveillance, epidemiology, and end results data. J Thorac Oncol. 2018; 13(6): 106-107.
Wozniak AJ, Kosty MP, Jahanzeb M, Brahmer JR, Spigel DR, Leon, Fish S, Flick ED, Hazard SJ, Lynch TJ Jr. Clinical outcomes in elderly patients with advanced non-smaill cell lung cancer: results from ARIES, a bevacizumab cohort Study. Clin Oncol (R Coll Radio). 2015; 27(4): 187-96.
Pass HI, Goparaju C, Espin-Garcia O, Donington J, Carbone M, Patel D, Chen Z, Gadgell S, Woznaik A, Chachoua A, Leighl N, Tsao MS, de Perros M, Xu W, Liu G. Plasma biomarker enrichment of clinical prognostic indices in malignant pleural mesothelioma. J Thorac Oncol. 2016; 11(6): 900-9.
Wozniak AJ. Is this as good as it gets?. J Oncol Pract. 2016; 2: 121-2.
Notable Achievements
Hillman Fellow for Innovative Team Science Cancer Research, 2020
Fellow, American Society of Clinical Oncology, 2018
Outstanding Teaching Award, Division of Hematology/Oncology, Wayne State University, 2018
Outstanding Teaching Award, Wane State University-School of Medicine, 2016
Frank Ellis Medal, The Royal College of Radiologists (Best paper published in Clinical Oncology, 2016
Top Docs, Hour Magazine -Detroit, 2016
Top Docs, Hour Magazine - Detroit, 2012-2014
CTEP-NCI-Joan K. Mauer Memorial Award for Excellence in Clinical Trial Audits and Quality Assurance, 2012
Top Docs,
Outstanding Teaching Award, Division of Hematology/Oncology Fellows, 2011